Vascular cognitive disorder. A biological and clinical overview

Neurochemical Research

Volumn 35, Issue 12, 2010, Pages 1933-1938

  Battistin, Leontino ^a,b   Cagnin, Annachiara ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; Biomarkers; Risk factors; Vascular cognitive disorder

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; GELATINASE A; GELATINASE B; NOTCH3 RECEPTOR; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; DEGENERATIVE DISEASE; DEMENTIA; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; MILD COGNITIVE IMPAIRMENT; MOLECULAR BIOLOGY; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; VASCULAR COGNITIVE DISORDER;

BIOLOGICAL MARKERS; DEMENTIA, VASCULAR; HUMANS; RISK FACTORS;

EID: 78651301462     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0346-5     Document Type: Article

References (33)

1. L Fratiglioni LJ Launer K Andersen, et al. 2000 Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group Neurology 54 S4 S9 10854354
2. Gorelick PB, Roman G, Mangone CA (1994) Vascular dementia. In: Gorelick PB, Alter MA (eds) Handbook of Neuroepidemiology. Mecel Dekker, New York, pp 197-214
3. Binswanger O (1894) Die Abgrenzung der allgemeinen progressiven paralyse. Berl. Klein. Wochenschr. 31:1102-1205, 1137-1139, 1180-1186
4. VC Hachinski MA Lassen J Marshall 1974 Multi-infarct dementia. A cause of mental deterioration in elderly Lancet 2 207 210 1:STN:280:DyaE2c3nslyjsA%3D%3D 10.1016/S0140-6736(74)91496-2 4135618
5. GC Roman P Sachdev DR Royall, et al. 2004 Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia Neurol Sci 226 81 87 10.1016/j.jns.2004.09.016
6. P Sachdev 1999 Vascular cognitive disorder Int J Geriatr Psychiatry 14 402 403 1:STN:280:DyaK1Mzhslakuw%3D%3D 10.1002/(SICI)1099-1166(199905)14: 5<402::AID-GPS958>3.0.CO;2-H 10389048
7. JT O'Brien T Erkinjuntti B Reisberg, et al. 2003 Vascular cognitive impairment Lancet Neurol 2 89 98 10.1016/S1474-4422(03)00305-3 12849265
8. Cagnin A, Battistin L (2007) Vascular dementia. In: Readerer Battistin (ed) Handbook of neurochemistry and molecular neurobiology. Springer-Verlag, Berlin-Eidelberg, pp 253-265
9. HC Chui JI Victoroff D Margolin, et al. 1992 Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer disease diagnostic and treatment centers (ADDTC) Neurology 42 473 480 1:STN:280:DyaK387psFCntA%3D%3D 1549205
10. GC Roman TK Tatemichi T Erkinjutti, et al. 1993 Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop Neurology 43 250 260 1:STN:280:DyaK3s7ntlaqsQ%3D%3D 8094895
11. Organization WorldHealth (1993) International classification of diseases. Tenth Revision. World Health Organization, Geneva
12. CC Price AL Jefferson JG Merino, et al. 2005 Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data Neurology 65 376 382 1:STN:280:DC%2BD2Mvit12jsg%3D%3D 10.1212/01.WNL.0000168877.06011.15 16087901
13. DR Royall GC Roman 2000 Differentiation of vascular dementia from AD on neuropsychological tests Neurology 55 604 606 1:STN:280:DC%2BD3cvhsFShtg%3D%3D 10953213
14. CG Ballard EJ Burton R Barber, et al. 2004 NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia Neurology 63 983 988 1:STN:280:DC%2BD2cvotlymtA%3D%3D 15452287
15. KA Jellinger 2007 The enigma of vascular cognitive disorder and vascular dementia Acta Neuropathol 113 349 388 10.1007/s00401-006-0185-2 17285295
16. G Lesser K Kandiah LS Libow, et al. 2001 Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease Dement Geriat Cogn Disord 12 138 145 1:CAS:528:DC%2BD3MXitFOisrg%3D 10.1159/000051248
17. RM Evans CL Emsley S Gao, et al. 2000 Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans Neurology 54 240 242 1:STN:280:DC%2BD3c7gtVWitg%3D%3D 10636159
18. M Kivipelto T Ngandu T Laatikainen, et al. 2006 Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study Lancet Neurol 5 735 741 10.1016/S1474-4422(06)70537-3 16914401
19. EP Helzner JA Luchsinger N Scarmeas, et al. 2009 Contribution of vascular risk factors to the progression in Alzheimer disease Arch Neurol 66 343 348 10.1001/archneur.66.3.343 19273753
20. SN Romas MX Tang L Berglund, et al. 1999 APOE genotype, plasma lipids, lipoproteins, and AD in community elderly Neurology 53 517 521 1:CAS:528:DyaK1MXlsleju7c%3D 10449113
21. ZS Tan S Seshadri A Beiser, et al. 2003 Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham study Arch Int Med 163 1053 1057 1:CAS:528:DC%2BD3sXkt1altrY%3D 10.1001/archinte.163.9.1053
22. M Kivipelto A Solomon 2006 Cholesterol as a risk factor for Alzheimer's disease-epidemiological evidence Acta Neurol Scand 114 50 57 10.1111/j.1600-0404.2006.00685.x
23. F Panza A D'Introno AM Colacicco, et al. 2006 Lipid metabolism in cognitive decline and dementia Brain Res Rev 51 275 292 1:CAS:528: DC%2BD28XlvFGnsr4%3D 10.1016/j.brainresrev.2005.11.007 16410024
24. F Panza V Solfrizzi A D'Introno, et al. 2009 Higher total cholesterol, cognitive decline, and dementia Neurobiol Aging 30 546 548 10.1016/j. neurobiolaging.2007.10.019 18179846
25. A Papassotiropoulos MA Wollmer M Tsolaki, et al. 2005 A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease J Clin Psychiatry 66 940 947 1:CAS:528:DC%2BD2MXpsVeqtLc%3D 10.4088/JCP.v66n0720 16013913
26. A Cagnin A ZAmbon G Zarantonello, et al. 2007 Serum lipoprotein profile and APOE genotype in Alzheimer's disease J Neural Transm Suppl 72 175 179 1:CAS:528:DC%2BD2sXhsVKns7nK 10.1007/978-3-211-73574-9-22 17982892
27. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347-360
28. BV Zlokovic 2008 The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 57 178 201 1:CAS:528:DC%2BD1cXhvVSrtrc%3D 10.1016/j.neuron.2008.01.003 18215617
29. GG Leblanc JF Meschia DT Stuss, et al. 2006 Genetics of vascular cognitive impairment. The opportunity and the challenges Stroke 37 248 255 10.1161/01.STR.0000195177.61184.49 16339474
30. AJC Slooter M-X Tang CM van Duijn, et al. 1997 Apolipoprotein E 4 and the risk of dementia with stroke: a population-based investigation JAMA 277 818 821 1:STN:280:DyaK2s3gsFajug%3D%3D 10.1001/jama.277.10.818 9052712
31. L Traykov AS Rigaud L Caputo, et al. 1999 Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease Eur J Neurology 6 415 421 1:STN:280:DyaK1M3pt12rtg%3D%3D 10.1046/j.1468-1331.1999.640415.x
32. C Briani A Cagnin L Gallo, et al. 2005 Anti-heparan sulphate antibodies and homocysteine: markers of vascular pathology? J Neurol Sci 229-230 215 218 10.1016/j.jns.2004.11.031 15760642
33. JC Adair J Charlie JE Dencoff, et al. 2004 Measurement of gelatinase B (MMP-9) in cerebrospinal fluid of patients with vascular dementia and Alzheimer disease Brain 35 159 162